Clinical trial
Corona-Virus-Disease 2019 (Covid-19) Antibody Responses in Cystic Fibrosis
NCT05012306 is registered in ClinicalTrials.gov with Universitätsklinikum Köln as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Corona-Virus-Disease 2019 (Covid-19) Antibody Responses in Cystic Fibrosis
- Lead sponsor
- Universitätsklinikum Köln
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 28, 2021
- Completion date
- May 31, 2024
- Enrollment
- 500 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.